abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Revenue Growth
54.26%
TTM · Period ending:
HQL Revenue Growth
Year-over-year change vs the same period a year earlier
Latest reported54.26%period ending
Latest reported54.26%period ending
HQL TTM Revenue YoY % (-37.84% → 54.26%)
Year-over-year change
High-resolution chart · PNG
HQL revenue growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Revenue Growth |
|---|---|
| 54.2578% | |
| -4.6826% | |
| -6.3472% | |
| -44.0093% | |
| 11.0073% | |
| -17.5854% | |
| -30.5673% | |
| -8.5739% | |
| 3.2618% | |
| 102.5517% | |
| 166.9731% | |
| 837.831% | |
| 735.1957% | |
| 122.7118% | |
| 211.4947% | |
| 63,614.8316% | |
| 32,533.5398% | |
| 13.0284% | |
| 25.016% | |
| 25.4809% | |
| 49.1795% | |
| 72.6397% | |
| -99.8874% | |
| -99.9406% | |
| -39.9571% | |
| -20.9837% | |
| 12.1425% | |
| 13.5776% | |
| -7.2141% | |
| 4.8246% | |
| 5.8957% | |
| 7.0423% | |
| -33.982% | |
| -53.1868% | |
| -31.3464% | |
| -12.1622% | |
| 16.2485% | |
| 62.3824% | |
| 90.2273% | |
| 163.6364% | |
| 105.6075% | |
| 30.1075% | |
| -13.7097% | |
| -40% | |
| -41.784% | |
| -42.8044% | |
| -7.7922% | |
| 41.8848% | |
| 94.9367% | |
| -37.8378% |